
Health Systems
The Algorithmic Quest to Slow Aging
New data suggests AI-developed drug candidates and GLP-1 weight-loss medications may influence biological aging, though evidence remains split between mouse models and early human trials.
LiveEdition 665
Sign inIndex
1 original story in the magazine.

Health Systems
New data suggests AI-developed drug candidates and GLP-1 weight-loss medications may influence biological aging, though evidence remains split between mouse models and early human trials.